Generic pharmaceuticals maker MSN Group on Thursday announced the cheapest Covid-19 treatment drug Favipiravir 200 mg at Rs 33 per tablet. The drug is named as Favilow and will be available in all pharmacies across India.
The drug will be launched on August 15 and will be manufactured from its formulation facility located in Bollaram, Hyderabad. The Hyderabad-based company said it is also planning to launch Favipiravir 400mg in the market soon.
Favipiravir has been approved by DCGI for the treatment of suspected or confirmed cases of coronavirus in adults and children suffering from mild to moderate Covid-19 symptoms.
The drug will be launched on August 15 and will be manufactured from its formulation facility located in Bollaram, Hyderabad. The Hyderabad-based company said it is also planning to launch Favipiravir 400mg in the market soon.
Favipiravir has been approved by DCGI for the treatment of suspected or confirmed cases of coronavirus in adults and children suffering from mild to moderate Covid-19 symptoms.